These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26907667)

  • 1. The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies.
    Li X; Zhong H
    Hematology; 2016 Jun; 21(5):263-71. PubMed ID: 26907667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in myeloid malignancies.
    Gordon JE; Wong JJ; Rasko JE
    Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNAs in hematological malignancies.
    Fatica A; Bozzoni I
    Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Brief Funct Genomic Proteomic; 2009 May; 8(3):184-93. PubMed ID: 19474126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting microRNA in hematologic malignancies.
    Han Z; Rosen ST; Querfeld C
    Curr Opin Oncol; 2020 Sep; 32(5):535-544. PubMed ID: 32657797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of microRNAs in adrenocortical tumors.
    Singh P; Soon PS; Feige JJ; Chabre O; Zhao JT; Cherradi N; Lalli E; Sidhu SB
    Mol Cell Endocrinol; 2012 Mar; 351(1):118-28. PubMed ID: 21996374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
    Barbarotto E; Calin GA
    Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: pivotal regulators in acute myeloid leukemia.
    Li M; Cui X; Guan H
    Ann Hematol; 2020 Mar; 99(3):399-412. PubMed ID: 31932900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies.
    Bacher U; Kohlmann A; Haferlach T
    Cancer Treat Rev; 2010 Dec; 36(8):637-46. PubMed ID: 20570445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
    Xie L; Jing R; Qi J; Lin Z; Ju S
    Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA: Defining a new niche in Leukemia.
    Fernandes Q
    Blood Rev; 2017 May; 31(3):129-138. PubMed ID: 28087197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insight into the role of miRNAs in leukemia.
    Zhang H; Chen Y
    Sci China C Life Sci; 2009 Mar; 52(3):224-31. PubMed ID: 19294347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between microRNA-155 and hematological malignancies].
    Xue H; Hua LM; Luo JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death.
    Schickel R; Boyerinas B; Park SM; Peter ME
    Oncogene; 2008 Oct; 27(45):5959-74. PubMed ID: 18836476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposite expression pattern of Src kinase Lyn in acute and chronic haematological malignancies.
    Hussein K; von Neuhoff N; Büsche G; Buhr T; Kreipe H; Bock O
    Ann Hematol; 2009 Nov; 88(11):1059-67. PubMed ID: 19290526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdissecting the role of microRNAs in the pathogenesis of prostate cancer.
    Ayub SG; Kaul D; Ayub T
    Cancer Genet; 2015 Jun; 208(6):289-302. PubMed ID: 26004033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma.
    Yu X; Li Z
    J Cell Mol Med; 2016 Jan; 20(1):10-6. PubMed ID: 26498914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in hematological malignancies.
    Lawrie CH
    Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities of microRNAs in lymphomas.
    De Tullio G; De Fazio V; Sgherza N; Minoia C; Serratì S; Merchionne F; Loseto G; Iacobazzi A; Rana A; Petrillo P; Silvestris N; Iacopino P; Guarini A
    Molecules; 2014 Sep; 19(9):14723-81. PubMed ID: 25232701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.